Israel Englander Decibel Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$2.41 - $4.81 $209,894 - $418,917
-87,093 Reduced 35.36%
159,224 $613,000
Q1 2023

May 15, 2023
SELL
$2.08 - $4.79 $504,329 - $1.16 Million
-242,466 Reduced 49.61%
246,317 $744,000
Q4 2022

Feb 14, 2023
BUY
$1.86 - $3.54 $318,973 - $607,078
171,491 Added 54.05%
488,783 $1 Million
Q3 2022

Nov 14, 2022
BUY
$3.82 - $5.61 $201,390 - $295,759
52,720 Added 19.93%
317,292 $1.1 Million

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email